These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 23067047)

  • 21. Peripheral arterial disease in patients with diabetes.
    Marso SP; Hiatt WR
    J Am Coll Cardiol; 2006 Mar; 47(5):921-9. PubMed ID: 16516072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peripheral and cerebrovascular atherosclerotic disease in diabetes mellitus.
    Mukherjee D
    Best Pract Res Clin Endocrinol Metab; 2009 Jun; 23(3):335-45. PubMed ID: 19520307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacologic risk factor treatment of peripheral arterial disease is lacking and requires vascular surgeon participation.
    Bianchi C; Montalvo V; Ou HW; Bishop V; Abou-Zamzam AM
    Ann Vasc Surg; 2007 Mar; 21(2):163-6. PubMed ID: 17349357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subclinical peripheral arterial disease and incompressible ankle arteries are both long-term prognostic factors in patients undergoing coronary artery bypass grafting.
    Aboyans V; Lacroix P; Postil A; Guilloux J; Rollé F; Cornu E; Laskar M
    J Am Coll Cardiol; 2005 Sep; 46(5):815-20. PubMed ID: 16139130
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of peripheral arterial disease on health-related quality of life in the Peripheral Arterial Disease Awareness, Risk, and Treatment: New Resources for Survival (PARTNERS) Program.
    Regensteiner JG; Hiatt WR; Coll JR; Criqui MH; Treat-Jacobson D; McDermott MM; Hirsch AT
    Vasc Med; 2008 Feb; 13(1):15-24. PubMed ID: 18372434
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapy insight: peripheral arterial disease and diabetes--from pathogenesis to treatment guidelines.
    Mohler ER
    Nat Clin Pract Cardiovasc Med; 2007 Mar; 4(3):151-62. PubMed ID: 17330127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic kidney disease has a more powerful impact on peripheral arterial disease than metabolic syndrome in Japanese type 2 diabetic patients.
    Tsunoda K; Shimajiri Y; Morita S; Furuta M; Kadoya Y; Yamada S; Nanjo K; Sanke T
    Metab Syndr Relat Disord; 2009 Aug; 7(4):323-6. PubMed ID: 19558271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atherosclerotic risk factor control in patients with peripheral arterial disease.
    Rehring TF; Sandhoff BG; Stolcpart RS; Merenich JA; Hollis HW
    J Vasc Surg; 2005 May; 41(5):816-22. PubMed ID: 15886666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Obliteration Index: a simple non-invasive tool for the assessment of peripheral vascular disease in chronic kidney disease.
    Saková R; Dusilová-Sulková S; Lopot F; Polakovic V
    J Nephrol; 2009; 22(4):534-46. PubMed ID: 19662610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospective evaluation of the relationship between C-reactive protein, D-dimer and progression of peripheral arterial disease.
    Musicant SE; Taylor LM; Peters D; Schuff RA; Urankar R; Landry GJ; Moneta GL
    J Vasc Surg; 2006 Apr; 43(4):772-80; discussion 780. PubMed ID: 16616235
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peripheral artery disease: therapeutic advances.
    Shamoun F; Sural N; Abela G
    Expert Rev Cardiovasc Ther; 2008 Apr; 6(4):539-53. PubMed ID: 18402543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Electrocardiographic abnormalities among dialysis naïve chronic kidney disease patients in Ilorin Nigeria.
    Chijioke A; Makusidi AM; Kolo PM
    Ann Afr Med; 2012; 11(1):21-6. PubMed ID: 22199043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kidney function and risk of peripheral arterial disease: results from the Atherosclerosis Risk in Communities (ARIC) Study.
    Wattanakit K; Folsom AR; Selvin E; Coresh J; Hirsch AT; Weatherley BD
    J Am Soc Nephrol; 2007 Feb; 18(2):629-36. PubMed ID: 17215445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of white blood cell count and peripheral arterial disease in patients with and without traditional risk factors.
    Chen JJ; Lin LY; Lee HH; Lai LP; Lin JL; Huang JJ; Tseng CD
    Angiology; 2010 May; 61(4):382-7. PubMed ID: 19689993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peripheral arterial disease: diagnosis, treatment, and systemic implications.
    Federman DG; Kravetz JD
    Clin Dermatol; 2007; 25(1):93-100. PubMed ID: 17276206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peripheral arterial disease. Medical management in primary care practice.
    Weiner SD; Reis ED; Kerstein MD
    Geriatrics; 2001 Apr; 56(4):20-2, 25-6, 29-30. PubMed ID: 11301719
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improvement in lower-extremity peripheral arterial disease by nocturnal hemodialysis.
    Chan CT; Mardirossian S; Faratro R; Richardson RM
    Am J Kidney Dis; 2003 Jan; 41(1):225-9. PubMed ID: 12500241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The prevalence of peripheral arterial disease in high risk subjects and coronary or cerebrovascular patients.
    Poredos P; Jug B
    Angiology; 2007; 58(3):309-15. PubMed ID: 17626985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel and traditional cardiovascular risk factors for peripheral arterial disease in incident-dialysis patients.
    Jaar BG; Plantinga LC; Astor BC; Fink NE; Longenecker C; Tracy RP; Marcovina SM; Powe NR; Coresh J
    Adv Chronic Kidney Dis; 2007 Jul; 14(3):304-13. PubMed ID: 17603986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endovascular treatment of peripheral vascular disease.
    Allaqaband S; Kirvaitis R; Jan F; Bajwa T
    Curr Probl Cardiol; 2009 Sep; 34(9):359-476. PubMed ID: 19664498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.